Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Inhibitors-DY-III-281
DY-III-281

Chemical Structure : DY-III-281

CAS No.:

DY-III-281

Catalog No.: PC-25814Not For Human Use, Lab Use Only.

DY-III-281 is a SARS-CoV-2 small-molecule entry inhibitor with IC50 of 0.62 uM and 0.44 uM for SARS-CoV-1-S and SARS-CoV-2-S pseudoviruses.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

DY-III-281 is a SARS-CoV-2 small-molecule entry inhibitor with IC50 of 0.62 uM and 0.44 uM for SARS-CoV-1-S and SARS-CoV-2-S pseudoviruses.
DY-III-281 is potent against the different VOCs Spikes (D614G, B.1.1.7, BA.4/5, XBB.1.5, BA.2.86, EG.5.1, HK.3, JN.1, KP.3.1.1, and XEC) or from SARS-CoV-1.
DY-III-281 promotes the RBD-up conformation.
DY-III-281 delays virus spread and decreases viral load in organs from SARS-CoV-2WA1-challenged mice.

Physicochemical Properties

M.Wt 391.31
Formula C16H27BrN2O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(2R,2'R)-3,3'-((5-bromo-1,3-phenylene)bis(oxy))bis(1-(dimethylamino)propan-2-ol)

References

1. Shilei Ding, et al. J Virol. 2025 Nov 25;99(11):e0103425.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: